Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history

European Journal of Preventive Cardiology 2026

View at publisher
Authors: Liming Yang
DOI: 10.1093/eurjpc/zwag353
Cited by: 1
References: 5

Abstract

Liming Yang; Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history, European Journal o

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Atherosclerosis and Cardiovascular Diseases Peroxisome Proliferator-Activated Receptors

Publication details

Journal / source
European Journal of Preventive Cardiology
Publisher
Oxford University Press (OUP)
Publication date
7 July 2026
Language
EN